High Ly6K mRNA expression in kidney cancer was significantly correlated with decreased one-year overall survival (dead, n=16 vs alive, n=55) and five-year overall survival (dead, n=12 vs alive, n=9) in Zhao [143] and TCGA [67] studies respectively. Here, LY6K is linked to kidney cancer.